News
The non-financial benefits of generics substitution
2014-10-30 Switching between different generic brands of metformin is a good cost-effective approach that does not adversely affect the quality of care for patients with type… Read More »
European doctors have insufficient knowledge of biosimilars
2014-10-28 The Alliance for Safe Biologic Medicines (ASBM), which represents patients and physicians, as well as originator biological and biosimilar medicines companies in the US, published… Read More »
Diabetes and high blood pressure generics in Europe
2014-10-24 Generics contribute value to the European Union (EU), according to a presentation by Mr Victor Lino Mendonça given at the International Generic Pharmaceutical Alliance (IGPA)’s… Read More »
Proposal in Brazil to exempt medicines from tax
2014-10-22 The Brazilian Government announced on 9 February 2014 that it is setting up a committee to evaluate whether to exempt medicines from tax in the… Read More »
GPhA proposes using manufacturer names to distinguish biosimilars
2014-10-20 The Generic Pharmaceutical Association (GPhA) has proposed a compromise naming scheme for biosimilars that it hopes will end the dispute over how to assign international… Read More »
Are biosimilars worth it?
2014-10-16 Will off-patent biological medicines offer the same cost savings as those seen with off-patent non-biological (chemically derived) medicines? A group of health economists based in… Read More »
EMA and FDA extend quality collaboration
2014-10-14 The European Medicines Agency (EMA) announced on 6 March 2014 that as of 1 April 2014 EMA and the US Food and Drug Administration (FDA)… Read More »
Brand-name drugs also cut healthcare costs
2014-10-10 Generics are often given all the praise when it comes to cutting costs for patients and payers, but, according to a piece in Forbes, brand-name… Read More »
How safe is Zarzio after five years’ clinical experience?
2014-10-08 The first filgrastim biosimilar was approved in Europe in 2008, prompting Dr Pere Gascón and co-authors to review the evidence relating to the efficacy and… Read More »
Generics contribution to availability of essential medicines
2014-10-06 The creation of Essential Medicines Lists (EMLs) within country healthcare systems is promoted by the World Health Organization (WHO) in order to improve the availability… Read More »
